Teen obesity, diabetes or high blood pressure may lead to prematurely aged arteries

May 06, 2020

DALLAS, May 6, 2020 -- Teenagers who have obesity, type 2 diabetes or high blood pressure may be more likely to have signs of premature blood vessel aging compared to teens without those health conditions, according to new research published today in the Journal of the American Heart Association, an open access journal of the American Heart Association.

Over five years, researchers evaluated 141 teens with normal weight; 156 who had obesity; and 151 who had type 2 diabetes, with an average age of 17.6 when the study began. At the end of five years, the teens with either obesity, type 2 diabetes or high systolic blood pressure - major risk factors for heart attacks and strokes later in life - were significantly more likely to have thicker and stiffer carotid arteries, the main blood vessel that leads to the brain.

"Our study demonstrates that the slow changes in blood vessels that lead to the development of atherosclerosis begins early in life," said lead study author Justin R. Ryder, Ph.D., assistant professor of pediatrics and associate director of research for the Center for Pediatric Obesity Medicine at the University of Minnesota Medical School in Minneapolis. Atherosclerosis is the slow narrowing of the arteries usually associated with natural aging, and it increases the risk of heart attacks, strokes and other cardiovascular events.

"Having obesity, type 2 diabetes or high systolic blood pressure were each independently associated with and equally predictive of having thicker and stiffer arteries among this group of young people. What surprised our team the most was that participants with higher systolic blood pressure compared to their peers in the study had a very similar risk as those with obesity or type 2 diabetes for thicker and stiffer blood vessels over time," said Ryder.

Carotid artery health was assessed by non-invasive ultrasound and pulse wave velocity. The ultrasound measured the thickness of the inner two layers of the blood vessel, known as carotid intima-media thickness. The pulse wave velocity gauges how fast blood flows through the vessels to determine arterial stiffness. Both measures were taken at the beginning of the study and five years later. The analysis concluded teens with obesity, type 2 diabetes or high systolic blood pressure had greater change in the thickness and stiffness of their arteries, compared to participants in the group with normal weight. This would suggest a greater risk of early heart attacks or strokes among the teens with obesity, type 2 diabetes or high systolic blood pressure.

"Although type 2 diabetes is treated aggressively in the U.S., obesity needs to be treated just as vigorously because it has the same increased risk for premature aging of the blood vessels, which is an early sign of cardiovascular dysfunction and a precursor to cardiovascular diseases in adulthood," according to Ryder.

Strengths of the study included its large study size of almost 150 teens in each group, for a total of 448 participants, and objective measurements of carotid artery health five years apart. A limitation of the research is that the teens will not be followed into adulthood to track if the premature aging of their blood vessels results in heart attacks, strokes and other cardiovascular conditions.
Co-authors are Elise Northrop, B.A.; Kyle D. Rudser, Ph.D.; Aaron S. Kelly, Ph.D.; Zhiqian Gao, Ph.D.; Philip R. Khoury, Ph.D.; Thomas R. Kimball, M.D.; Lawrence M. Dolan, M.D.; and Elaine M. Urbina, M.D., M.S.

The National Institutes of Health, the National Center for Research Resources and the National Center for Advancing Translational Sciences funded this study.

Additional Resources:

Available multimedia is on right column of release link - https://newsroom.heart.org/news/teen-obesity-diabetes-or-high-blood-pressure-may-lead-to-prematurely-aged-arteries?preview=3a24f27b7e527f4806be198d930a099e

Statements and conclusions of study authors published in American Heart Association scientific journals are solely those of the study authors and do not necessarily reflect the Association's policy or position. The Association makes no representation or guarantee as to their accuracy or reliability. The Association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific Association programs and events. The Association has strict policies to prevent these relationships from influencing the science content. Revenues from pharmaceutical and device corporations and health insurance providers are available at https://www.heart.org/en/about-us/aha-financial-information.

About the American Heart Association

The American Heart Association is a relentless force for a world of longer, healthier lives. We are dedicated to ensuring equitable health in all communities. Through collaboration with numerous organizations, and powered by millions of volunteers, we fund innovative research, advocate for the public's health and share lifesaving resources. The Dallas-based organization has been a leading source of health information for nearly a century. Connect with us on heart.org, Facebook, Twitter or by calling 1-800-AHA-USA1.

American Heart Association

Related Diabetes Articles from Brightsurf:

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Diabetes, but not diabetes drug, linked to poor pregnancy outcomes
New research indicates that pregnant women with pre-gestational diabetes who take metformin are at a higher risk for adverse pregnancy outcomes -- such as major birth defects and pregnancy loss -- than the general population, but their increased risk is not due to metformin but diabetes.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.